Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Organon's fertility hormone approved in Canada

Aug. 13, 1997

Crinone approved in Mexico

Aug. 13, 1997

Cangene signs licensing and distribution agreement for Leucotropin

Aug. 12, 1997

RPR seeks U.S. and European approval for estrogen/progestogen transdermal patch

Aug. 12, 1997

Studies imply role of relaxin in infertility treatments

Aug. 12, 1997

Granocyte approved for marketing in 14 additional countries

Aug. 11, 1997

Analysis of Macritonin phase II/III trial complete; Cortecs to seek European approval

Aug. 11, 1997

Etidronate reduces fractures in corticosteroid-induced osteoporosis

Aug. 11, 1997

Vanadium compounds for treatment of diabetes

Aug. 8, 1997

New HRT option from Organon

Aug. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld Science
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...